Selenocyanate‐Containing Molecules as Trypanosoma cruzi Inhibitors: Impact of Regioisomerism, Conformational Restriction, and Second‐Ring Substitution

As a continuation of the project aimed at searching for new chemotherapeuticagents against Chagas disease or American trypanosomiasis, new selenocyanate derivatives are designed, synthesized, and biologically evaluated against the clinically more relevant dividing amastigote form of Trypanosoma cruzi, the etiologic agent of this illness. Furthermore, as all the title compounds are fluorine‐containing molecules, it seemed to be reasonable to explore the role of fluorine atoms in the aromatic system and to determine the optimal position at the terminal phenoxy group, and therefore, various regioisomers are prepared. The conformationally restricted selenocyates structurally related to WC‐9Se exhibited improved antiparasitic activity compared to the lead drugs, Out to be extremely potent inhibitors of T. cruzi growth. In particular, (±)‐5‐(3‐fluorophenoxy)‐2‐(selenocyanatomethyl)−2,3‐dihydrobenzofuran exhibited an EC50 value of 0.032 µM, which resulted in the most potent selenocyanate developed in the laboratory. The presence of the fluorine atom together with the rigidity of the molecules are beneficial for the anti‐T. cruzi effect. The resulting antiparasitic activity provides further insight into the role of the selenocyanate group in its effective and putative anti‐T. cruzi action.

• Publication year

  2025

• Venue

  ChemMedChem

• Publication date

  2025-11-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/cmdc.202500658PMID 41218016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Conformational and Electron Density Analysis of Bicyclo[3.1.0] hexanes: All Roads Lead to Boats

  2024cited by this paper
• Organoselenium Compounds in Medicinal Chemistry

  2024cited by this paper
• Selenium-Substituted Conjugated Small Molecule: Synthesis, Spectroscopic, Computational Studies, Antioxidant Activity, and Molecular Docking

  2024cited by this paper
• The Ups and Downs in Drug Design: Adventures in Medicinal Chemistry. By Victor E. Marquez

  2023cited by this paper
• Organoselenium compounds. Chemistry and applications in organic synthesis.

  2023cited by this paper
• Ebselen derivatives inhibit SARS-CoV-2 replication by inhibition of its essential proteins: PLpro and Mpro proteases, and nsp14 guanine N7-methyltransferase

  2023cited by this paper
• Conceptual DFT, QTAIM, and Molecular Docking Approaches to Characterize the T-Type Calcium Channel Blocker Anandamide

  2022cited by this paper
• The Se–S Bond Formation in the Covalent Inhibition Mechanism of SARS-CoV-2 Main Protease by Ebselen-like Inhibitors: A Computational Study

  2021cited by this paper
• Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2

  2021cited by this paper
• A rapid method for analyzing the chemical bond from energy densities calculations at the bond critical point

  2020cited by this paper
• Mechanisms of ebselen as a therapeutic and its pharmacology applications.

  2020cited by this paper
• FDA new drug approvals in Q3 2020

  2020cited by this paper
• Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease

  2020cited by this paper
• Synthetic and Mechanistic Studies on 2,3-Dihydrobenzo[b][1,4]-oxaselenines Formation from Selenocyanates

  2020cited by this paper
• Calculation of the Global and Local Conceptual DFT Indices for the Prediction of the Chemical Reactivity Properties of Papuamides A–F Marine Drugs

  2019cited by this paper
• Further insights of selenium-containing analogues of WC-9 against Trypanosoma cruzi.

  2019cited by this paper
• Behavioral Counseling Training for Primary Care Providers: Immersive Virtual Simulation as a Training Tool

  2019cited by this paper
• Chagas Disease: From Discovery to a Worldwide Health Problem

  2019cited by this paper
• Selenium versus sulfur: Reversibility of chemical reactions and resistance to permanent oxidation in proteins and nucleic acids.

  2018cited by this paper
• Selenium-containing analogues of WC-9 are extremely potent inhibitors of Trypanosoma cruzi proliferation.

  2017cited by this paper
• Thermal and Photoinduced Copper-Promoted C-Se Bond Formation: Synthesis of 2-Alkyl-1,2-benzisoselenazol-3(2H)-ones and Evaluation against Mycobacterium tuberculosis.

  2017cited by this paper
• Access to benznidazole for Chagas disease in the United States—Cautious optimism?

  2017cited by this paper
• Applications of the Conceptual Density Functional Theory Indices to Organic Chemistry Reactivity

  2016cited by this paper
• Activity of Fluorine‐Containing Analogues of WC‐9 and Structurally Related Analogues against Two Intracellular Parasites: Trypanosoma cruzi and Toxoplasma gondii

  2016cited by this paper
• Benznidazole Use among Patients with Chronic Chagas' Cardiomyopathy in an Endemic Region of Brazil

  2016cited by this paper
• Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions

  2016cited by this paper
• Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015)

  2016cited by this paper
• WC-9 a Lead Drug with Great Prospects for American Trypanosomiasis and Toxoplasmosis.

  2016cited by this paper
• Aryloxyethyl Thiocyanates Are Potent Growth Inhibitors of Trypanosoma cruzi and Toxoplasma gondii

  2015cited by this paper
• Potential new clinical therapies for Chagas disease

  2014cited by this paper
• Synthesis and application of palladium precatalysts that accommodate extremely bulky di-tert-butylphosphino biaryl ligands.

  2013cited by this paper
• Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents.

  2013cited by this paper
• Towards a Paradigm Shift in the Treatment of Chronic Chagas Disease

  2013cited by this paper
• Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents.

  2013cited by this paper
• Ebsulfur Is a Benzisothiazolone Cytocidal Inhibitor Targeting the Trypanothione Reductase of Trypanosoma brucei *

  2013cited by this paper
• Selenium-containing polymers: promising biomaterials for controlled release and enzyme mimics.

  2013cited by this paper
• In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds

  2010cited by this paper
• Chagas disease: a Latin American health problem becoming a world health problem.

  2010cited by this paper
• Orthogonal Cu- and Pd-based catalyst systems for the O- and N-arylation of aminophenols.

  2009cited by this paper
• A versatile catalyst system for Suzuki-Miyaura cross-coupling reactions of C(sp(2))-tosylates and mesylates.

  2009cited by this paper
• A highly active catalyst for Pd-catalyzed amination reactions: cross-coupling reactions using aryl mesylates and the highly selective monoarylation of primary amines using aryl chlorides.

  2008cited by this paper
• The Quantum Theory of Atoms in Molecules

  2007cited by this paper
• Fluorine-containing aryloxyethyl thiocyanate derivatives are potent inhibitors of Trypanosoma cruzi and Toxoplasma gondii proliferation.

  2007cited by this paper
• Kinetic Characterization of Squalene Synthase from Trypanosoma cruzi: Selective Inhibition by Quinuclidine Derivatives

  2007cited by this paper
• Claisen rearrangement over the past nine decades.

  2004cited by this paper
• Claisen rearrangement over the past nine decades.

  2004cited by this paper
• Organoselenium compounds as potential therapeutic and chemopreventive agents: a review.

  2004cited by this paper
• Electrophilicity index as a possible descriptor of biological activity.

  2004cited by this paper
• Mechanism of Action of 4-Phenoxyphenoxyethyl Thiocyanate (WC-9) against Trypanosoma cruzi, the Causative Agent of Chagas’ Disease

  2003cited by this paper
• Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.

  2003cited by this paper
• Specific chemotherapy of Chagas disease: controversies and advances.

  2003cited by this paper
• A general, efficient, and inexpensive catalyst system for the coupling of aryl iodides and thiols.

  2002cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi.

  1998cited by this paper
• Truncation of human squalene synthase yields active, crystallizable protein.

  1998cited by this paper
• Sterol biosynthesis inhibitors: potential chemotherapeutics against Chagas disease.

  1997cited by this paper
• Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

  1988cited by this paper
• Density-functional exchange-energy approximation with correct asymptotic behavior.

  1988cited by this paper
• Biology of Trypanosoma cruzi.

  1973cited by this paper

• No citing papers are available for this paper.